Accueil Biotechnologie AryoGen Pharmed
A

AryoGen Pharmed

Profil géré par Bizz Id
Iran 201-500 2010

Description

AryoGen Pharmed est une société biopharmaceutique iranienne du groupe CinnaGen qui produit des biosimilaires : anticorps monoclonaux, protéines de fusion et facteurs de coagulation recombinants. Selon son site, elle exporte vers 29 pays.

Produits

12 produits
Bevacizumab

Brand: Stivant. Bevacizumab biosimilar. Metastatic colorectal cancer, progressive glioblastoma, NSCLC, advanced or metastatic kidney cancer, epithelial ovarian, fallopian tube and primary peritoneal cancer, cervical cancer and metastatic breast cancer.

Produit fini

Vérifié le 2026-10-21

Bevacizumab: see suppliers →

Denosumab (Artenix)

Brand: Artenix. Monoclonal IgG2 antibody binding RANKL. Indication not stated on the website.

Produit fini

Vérifié le 2026-10-21

Denosumab: see suppliers →

Denosumab (Arylia)

Brand: Arylia. Human IgG2 monoclonal antibody binding RANKL. Osteoporosis (the website describes postmenopausal, male and treatment-related osteoporosis).

Produit fini

Vérifié le 2026-10-21

Denosumab: see suppliers →

Dupilumab

Brand: Aryxent. Monoclonal antibody blocking IL-4 and IL-13. Atopic dermatitis, asthma, eosinophilic esophagitis, chronic spontaneous urticaria, prurigo nodularis and COPD. Aryxent 200 and Aryxent 300 presentations.

Produit fini

Vérifié le 2026-10-21

Dupilumab: see suppliers →

Efmoroctocog alfa

Brand: Coageight. Recombinant coagulation factor VIII, Fc fusion protein, produced in CHO cells. Treatment and prevention of bleeding in haemophilia A, all age groups.

Produit fini

Vérifié le 2026-10-21

Efmoroctocog alfa: see suppliers →

Etanercept

Brand: Altebrel. Etanercept biosimilar, TNF-blocking fusion protein produced in CHO cells. Rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis-related arthritis and plaque psoriasis. Prefilled syringes 25 mg and 50 mg.

Produit fini

Vérifié le 2026-10-21

Etanercept: see suppliers →

Infliximab

Brand: Rheuflix. Contains infliximab; chronic inflammatory diseases, particularly rheumatoid arthritis.

Produit fini

Vérifié le 2026-10-21

Infliximab: see suppliers →

Recombinant activated human blood coagulation factor VIIa (rFVIIa)

Brand: AryoSeven. Glycoprotein produced in BHK cells by recombinant technology. Control, treatment and prevention of bleeding in congenital haemophilia A or B with inhibitors, acquired haemophilia, congenital factor VII deficiency and Glanzmann's thrombasthenia. Marketed as 1.2 mg (60 KIU), 2.4 mg (120 KIU) and 4.8 mg (240 KIU) lyophilised powder for injection.

Comercializado (mercado no indicado)

Dossier déposé

Produit fini

Vérifié le 2026-10-21

Rituximab

Brand: Zytux. Rituximab biosimilar, chimeric monoclonal antibody produced in CHO cells. Non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, GPA and MPA, pemphigus vulgaris. 100 mg and 500 mg vials for infusion.

Produit fini

Vérifié le 2026-10-21

Rituximab: see suppliers →

Tocilizumab

Brand: Temziva. Contains tocilizumab (IL-6 blocker). Cytokine release syndrome (CRS) in adults and children aged 2 and older with confirmed COVID-19. 400 mg/20 mL vial.

Aprobado «Food and Drug Administration» (país no indicado)

Dossier déposé

Produit fini

Vérifié le 2026-10-21

Tocilizumab: see suppliers →

Trastuzumab

Brand: AryoTrust. Trastuzumab biosimilar produced in recombinant CHO cells. HER2-overexpressing early and metastatic breast cancer and metastatic gastric cancer. Lyophilised powder for infusion, 150 mg and 440 mg.

Produit fini

Vérifié le 2026-10-21

Trastuzumab: see suppliers →

Vedolizumab

Brand: VedAryo. Humanized IgG1 monoclonal antibody binding integrin α4β7, produced in CHO cells.

Produit fini

Vérifié le 2026-10-21

Vedolizumab: see suppliers →

Contacter l'entreprise

Inscrivez-vous gratuitement pour voir les coordonnées de cette entreprise et la contacter.

S'inscrire - Gratuit